Yuusuke Umeda Selected Research

Therapeutics

10/2018	Efficacy and safety of trelagliptin in combination with insulin therapy in Japanese patients with type 2 diabetes: Results from a randomized, Phase IV study.
1/2018	A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuusuke Umeda Research Topics

Disease

1	Chronic Kidney Failure (Chronic Renal Failure) 03/2020
1	Diabetes Mellitus 03/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 10/2018
1	Essential Hypertension 01/2018

Drug/Important Bio-Agent (IBA)

2	trelagliptinIBA 03/2020 - 10/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2020
1	CreatinineIBA 03/2020
1	Renin InhibitorsIBA 01/2019
1	Insulin (Novolin)FDA Link 10/2018
1	Angiotensin Receptor AntagonistsIBA 01/2018
1	azilsartanIBA 01/2018
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2018
1	DiureticsIBA 01/2018
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2018
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2018

Therapy/Procedure

2	Therapeutics 10/2018 - 01/2018
1	Renal Dialysis (Hemodialysis) 03/2020
1	Exercise Therapy (Therapy, Exercise) 03/2020